Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / *W EXP 09/02/202
-
Total 13F shares
-
2,217,523
-
Share change
-
+112,626
-
Total reported value
-
$102,669
-
Price per share
-
$0.05
-
Number of holders
-
12
-
Value change
-
+$5,419
-
Number of buys
-
3
-
Number of sells
-
2
Institutional Holders of ROCKET PHARMACEUTICALS, INC. - *W EXP 09/02/202 (RCKTW) as of Q1 2025
As of 31 Mar 2025,
ROCKET PHARMACEUTICALS, INC. - *W EXP 09/02/202 (RCKTW) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,217,523 shares.
The largest 10 holders included
Walleye Capital LLC, Sio Capital Management, LLC, RTW INVESTMENTS, LP, CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, SILVERARC CAPITAL MANAGEMENT, LLC, Walleye Trading LLC, LMR Partners LLP, Affinity Asset Advisors, LLC, and Virtu Financial LLC.
This page lists
12
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.